JPRN-UMIN000016071已完成未知
Phase II Study of Carboplatin+nab-Paclitaxel for Non-small Cell Lung Cancer with Interstitial Pneumonitis Study of evaluating SPARC expression - Study of evaluating SPARC expression in Lung Cancer with Interstitial Pneumonitis
Yushima Lung Cancer Oncology Group (YLOG)0 个研究点目标入组 30 人开始时间: 2014年12月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
recruiting
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The cases excepting the above.
研究者
相似试验
已完成
2 期
Phase II study of Carboplatin plus nab-Paclitaxel for advanced non-small cell lung cancer patients with interstitial lung diseaseAdvanced non-small cell lung cancer with interstitial lung diseaseJPRN-UMIN000012989Kanagawa Cardiovascular and Respiratory Center90
已完成
2 期
Phase 2 study of Carboplatin plus nab-Paclitaxel for patients with PS 2 advanced NSCLC(TORG1426)on small cell lung cancerJPRN-UMIN000019458PO Thoracic Oncology Research Group42
招募中
2 期
Phase II Study of Nab-paclitaxel and Carboplatin Plus Bevacizumab as First-Line Chemotherapy for Reccurent or stage IIIB and IV Nonsquamous Non-Small-Cell Lung Cancer (ALCT004)on-squamous non-small-cell lung cancerJPRN-UMIN000013310Kyorin University School of Medicine33
已完成
2 期
Phase II study of nab-paclitaxel and carboplatin with concurrent thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancerJPRN-UMIN000011681Gifu Municipal Hospital32
已完成
2 期
Phase II study of Carboplatin + nab-Paclitaxel followed by nab-Paclitaxel with chemotherapy naive advanced Non- Small Cell Lung CancerChemotherapy naive non-small cell lung cancerJPRN-UMIN000015144Fukuoka University School of Medicine40